# Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin

> **NCT03044873** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 20 (actual)

## Conditions studied

- Autoimmune Diseases
- Inflammatory Diseases

## Interventions

- **DRUG:** BMS-986165
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT03044873
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-02
- **Primary completion:** 2017-03-14
- **Final completion:** 2017-03-27
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03044873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03044873, "Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03044873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*